A comprehensive molecular characterization of a claudin-low luminal B breast tumor.

doi:10.1186/s13062-024-00482-1

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

A comprehensive molecular characterization of a claudin-low luminal B breast tumor.

Biology direct - 16 Aug 2024

Giovannini Sara, Smirnov Artem, Concetti Livia, Scimeca Manuel, Mauriello Alessandro, Bischof Julia, Rovella Valentina, Melino Gerry, Buonomo Claudio Oreste, Candi Eleonora, Bernassola Francesca

Abstract excerpt

Breast cancer is the most common cause of death from cancer in women. Here, we present the case of a 43-year-old woman, who received a diagnosis of claudin-low luminal B breast cancer. The lesion revealed to be a poorly differentiated high-grade infiltrating ductal carcinoma, which was strongly estrogen receptor (ER)/progesterone receptor (PR) positive and human epidermal growth factor receptor (HER2) negative....

Topics

Humans
Female
Adult
Breast Neoplasms
Claudins
Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 39152485
DOI: 10.1186/s13062-024-00482-1
PMCID: PMC11328405

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics